Japan Intellectual Property Rights: ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF

Japan, Nov. 4 -- DANA FARBER CANCER INSTITUTE INC has got intellectual property rights for 'ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF.' Other related details are as follows:

Application Number: JP,2025-137145

Category (FI): C07D513/04,301,A61K31/437,C07D487/04,140,A61K31/407,C07D495/04,103,C07D495/04,105@Z,A61K31/519,A61K31/4365,C07D495/04,105@A,A61K31/53,A61K31/5377,A61K31/506,A61K39/395@T,A61K39/395@P,A61K45/00,A61P43/00,111,A61P35/00,A61P11/00,A61P25/00,A61P15/00,A61P13/08,A61P5/14,A61P1/00,A61K31/517,C07D401/14,A61K31/4725

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Aug. 20, 2025

Publication Date: Nov. 18, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.